Earlier this month, The Clatterbridge Cancer Centre hosted doctors in training to prepare them for their upcoming Fellow of the Royal College of Radiologists (FRCR) clinical oncology Part 2B Exams.

The FRCR Part 2B examines candidates on all aspects of clinical oncology. Clinical oncologists use both radiotherapy and medication treatments to treat patients and the exam tests trainees on clinical decision making, radiotherapy planning skills and clear communication. All future clinical oncologists have to obtain this qualification as part of their training.

Group.jpgStaff from across The Clatterbridge Cancer Centre joined in the session to support the participants and give their expert advice on key aspects of clinical oncology relevant to the exam. Staff supporting included some of our Consultant Clinical oncologists as well as consultant radiographers, senior clinical oncology registrars and medical educationstaff.

Clinical oncology registrars from across the country took part in the session online, with doctors joining from Newcastle, London, Belfast, Sheffield and as far afield as Malaysia.

The Clatterbridge Cancer Centre is renowned for the excellent standard of training it offers to doctors in training, with the session receiving excellent feedback with participants praising the organisation of the course and its usefulness in preparing them for their upcoming exams.

Alex Connor Wil Jas.jpgDr Jas Latif (pictured right), Consultant in clinical oncology at The Clatterbridge Cancer Centre, led the session. She said: “The turn out from colleagues across the Trust to support doctors in training at this session is testament to the high level of education we offer here. Thank you so much to them for giving up their time to instil their knowledge and help candidates feel more confident in their upcoming exam.”

“The FRCR Part 2B Exam is a high-pressured exam, essential to the training of any clinical oncologist. We want to ensure candidates are as prepared as possible to take on the exam. The more knowledge they have, ultimately, the better care we can all provide to patients of the future.”